| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | Chief Executive Officer +4 more
4 companies
Foehr Matthew W is a President And CEO at OmniAb, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 3 buys and 8 sells.
Estimated insider holdings value: $45.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | OABI Omniab, Inc. | President And CEO | Sale+OE | 20,754 | $1.70 | $35,281.80 | -0.5% | - | - | |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Director | Sale+OE | 16,000 | $35.11 | $561,694.40 | -10.8% | -6.9% | - | |
| Dec 8, 2025 | OABI Omniab, Inc. | President And CEO | Sale+OE | 13,666 | $1.96 | $26,785.36 | -0.3% | -2.0% | - | |
| Apr 7, 2025 | OABI Omniab, Inc. | President And CEO | Sale+OE | 19,382 | $2.00 | $38,764.00 | -0.5% | -10.5% | -27.8% | |
| Feb 19, 2025 | OABI Omniab, Inc. | President And CEO | Sale+OE | 33,486 | $3.67 | $123,033.26 | -0.4% | -58.0% | -53.4% | |
| Jan 21, 2025 | OABI Omniab, Inc. | President And CEO | Sell | 41,811 | $3.24 | $135,467.64 | -1.1% | -43.2% | -37.6% | |
| Dec 9, 2024 | OABI Omniab, Inc. | President And CEO | Sale+OE | 13,634 | $4.13 | $56,308.42 | -0.4% | -20.0% | -51.0% | |
| May 24, 2024 | OABI Omniab, Inc. | President And CEO | Buy | 240,000 | $4.42 | $1,059,840.00 | +7.3% | -7.3% | -68.6% | |
| Mar 22, 2024 | OABI Omniab, Inc. | President And CEO | Buy | 225,000 | $5.19 | $1,167,750.00 | +8.4% | -20.9% | -50.7% | |
| Dec 12, 2023 | OABI Omniab, Inc. | Chief Executive Officer | Buy | 200,000 | $5.05 | $1,010,000.00 | +8.2% | +7.3% | -20.0% |